| Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection (NCT05304455) | Northern Jiangsu People's Hospital | 2022-04-01 |
| Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis (NCT04967573) | Shanghai Zhongshan Hospital | 2021-08-01 |
| A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev (NCT04649489) | Jia Fan | 2021-04-19 |
| Collection of the Thrombo-VaxCov Cohort (NCT04889326) | University Hospital, Lille | 2021-04-02 |
| Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer (NCT04724460) | Takeshi Morimoto | 2021-02-18 |
| Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） (NCT04645550) | Northern Jiangsu People's Hospital | 2020-11-22 |
| Prospective Epidemiological Study of Upper Limb Venous Thrombosis (NCT04339894) | Nantes University Hospital | 2020-08-04 |
| JETi Lower Extremity Venous Thrombosis (NCT07027878) | Abbott Medical Devices | 2020-08-03 |
| Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis (NCT04156230) | Dae Hyuk Moon | 2020-01-13 |
| Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers (NCT04036656) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-08-01 |
| Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (NCT03895502) | Takeshi Morimoto | 2019-05-27 |
| A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD (NCT03945045) | National Taiwan University Hospital | 2019-05-21 |
| Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial (NCT02767232) | University of Colorado, Denver | 2018-07-01 |
| PeriOperative ISchemic Evaluation-3 Trial (NCT03505723) | Population Health Research Institute | 2018-06-27 |
| Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation (NCT07699796) | Heart, Artery, and Vein Center of Fresno | 2018-03-06 |
| A Preliminary Clinical Usability Study for the Recovery Force DVT II Cuff (NCT03328624) | University of Southern California | 2018-01-23 |
| Tranexamic Acid and Blood Clots in Knee Surgery (NCT02867163) | University of New Mexico | 2017-05-16 |
| Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion (NCT02752984) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2016-04-01 |
| Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study (NCT02581176) | University Hospital, Akershus | 2016-04-01 |
| Utilization of TEG to Monitor Rivaroxaban Activity (NCT02651909) | Matthew Neal MD | 2016-04-01 |
| Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients (NCT02697123) | Baylor College of Medicine | 2016-02-01 |
| Deep Venous Thrombosis After Hepatobiliopancreatic Surgery (NCT02649023) | Technische Universität Dresden | 2016-01-01 |
| Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. (NCT02597218) | Hospital Italiano de Buenos Aires | 2015-10-01 |
| Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System (NCT02567903) | Groene Hart Ziekenhuis | 2015-09-01 |
| Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer (NCT03001544) | Translational Sciences, Inc. | 2015-07-01 |
| XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis (NCT02506985) | Susan Smyth | 2015-07-01 |
| Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden) (NCT02468102) | Bayer | 2015-06-15 |
| Free DNA and Nucleosome Concentrations in Pathological Pregnancies (NCT01736826) | Centre Hospitalier Universitaire de Nīmes | 2015-06-01 |
| Risk Prediction of Venous Thromboembolism in Critically Ill (NCT03773939) | University Medical Center Groningen | 2015-03-27 |
| Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis (NCT02264964) | Shanghai Changzheng Hospital | 2015-01-01 |
| Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis (NCT02414802) | Xuzhou Medical University | 2014-12-01 |
| Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial (NCT02600260) | University of Sao Paulo General Hospital | 2014-12-01 |
| Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis (NCT02335580) | General Hospital of Shenyang Military Region | 2014-12-01 |
| Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection (NCT02247414) | Yangzhou University | 2014-09-01 |
| Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy (NCT02238444) | Yangzhou University | 2014-09-01 |
| Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis (NCT01999179) | Medical College of Wisconsin | 2014-06-01 |
| Educating Nurses About Venous Thromboembolism (VTE) Prevention (NCT02301793) | Johns Hopkins University | 2014-04-01 |
| Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease (NCT02062021) | University College, London | 2014-01-01 |
| Long Term Outcomes of Venous Thromboembolism (NCT02268630) | Ostfold Hospital Trust | 2014-01-01 |
| A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower Limb (NCT01894997) | National University of Ireland, Galway, Ireland | 2014-01-01 |
| Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection (NCT02258958) | McMaster University | 2014-01-01 |
| Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy (NCT02264743) | Royal Brompton & Harefield NHS Foundation Trust | 2013-11-01 |
| Lower Limb Blood Flow Geko vs Foot Pump (NCT03317145) | Hampshire Hospitals NHS Foundation Trust | 2013-07-24 |
| Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) (NCT01855100) | Bayer | 2013-07-01 |
| Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation (NCT02161965) | University Hospital, Angers | 2013-05-21 |
| Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow (NCT01862471) | National University of Ireland, Galway, Ireland | 2013-05-01 |
| Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication (NCT01805544) | Bayer | 2013-05-01 |
| Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator Procedures (NCT01717495) | University of Sao Paulo | 2013-04-01 |
| Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins (NCT01857050) | Meir Medical Center | 2013-04-01 |
| Oral Rivaroxaban in Children With Venous Thrombosis (NCT01684423) | Bayer | 2013-02-19 |
| A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (NCT01662908) | Daiichi Sankyo | 2012-08-01 |
| Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (NCT01619007) | Bayer | 2012-06-01 |
| Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis (NCT01779648) | Seoul National University Hospital | 2012-03-01 |
| Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands) (NCT01947985) | Bayer | 2012-02-01 |
| Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care (NCT01495429) | University of Michigan | 2012-01-01 |
| Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy (NCT02584842) | University Hospital, Basel, Switzerland | 2012-01-01 |
| Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK) (NCT01947998) | Bayer | 2011-12-22 |
| Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany) (NCT01947959) | Bayer | 2011-12-22 |
| Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis (NCT01482273) | Insel Gruppe AG, University Hospital Bern | 2011-11-01 |
| Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture (NCT01317160) | Karolinska University Hospital | 2011-03-01 |
| The Risk of Venous Clotting in Patients After Renal Transplant (NCT01413464) | St. Joseph's Healthcare Hamilton | 2011-03-01 |
| Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis (NCT01164540) | AstraZeneca | 2011-02-01 |
| The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses (NCT01406795) | Stanford University | 2010-12-01 |
| Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (NCT01252420) | Monash Medical Centre | 2010-11-01 |
| Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects (NCT01145859) | Bayer | 2010-11-01 |
| Vasculaire Compression System Increases Flow Velocity in the Femoral Vein (NCT01240330) | Venous Health Systems, Inc. | 2010-08-01 |
| Registry of AngioJet Use in the Peripheral Vascular System (NCT01086215) | Boston Scientific Corporation | 2010-01-01 |
| Safer Warfarin Treatment (NCT01042067) | Oslo University Hospital | 2010-01-01 |
| Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (NCT00790335) | Washington University School of Medicine | 2009-11-01 |
| Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). (NCT00986154) | Daiichi Sankyo | 2009-10-01 |
| Clarification of Optimal Anticoagulation Through Genetics (NCT00839657) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-09-01 |
| Ongoing Registry of Deep Venous Reconstructions (NCT02650453) | Maastricht University Medical Center | 2009-09-01 |
| Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. (NCT00878826) | Stanford University | 2009-05-01 |
| Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer (NCT00786422) | Bayer | 2009-05-01 |
| Obstructive Sleep Apnea and Venous Thromboembolism (NCT01051297) | University of Missouri-Columbia | 2009-03-01 |
| Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis (NCT00808626) | Temple University | 2008-12-01 |
| Switching Study From Warfarin to Rivaroxaban (NCT01507051) | Bayer | 2008-11-01 |
| Personalized Warfarin Dosing by Genomics and Computational Intelligence (NCT00872079) | US Department of Veterans Affairs | 2008-09-01 |
| Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters (NCT00728819) | University of Pennsylvania | 2008-08-01 |
| Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism (NCT00643201) | Bristol-Myers Squibb | 2008-07-01 |
| Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism (NCT00633893) | Bristol-Myers Squibb | 2008-05-01 |
| Evaluation of the Duration of Therapy for Thrombosis in Children (NCT00687882) | Johns Hopkins All Children's Hospital | 2008-03-01 |
| Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients (NCT00521885) | Lehigh Valley Hospital | 2007-09-01 |
| Study Of Lybrel In Relation To Venous Thromboembolism (NCT01297348) | Pfizer | 2007-07-01 |
| Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness (NCT00457002) | Bristol-Myers Squibb | 2007-06-01 |
| Venous Thromboembolism Taskforce Audit Program (NCT00535171) | Sanofi | 2007-06-01 |
| Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery (NCT01608906) | University of Colorado, Denver | 2007-05-01 |
| Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy (NCT00539942) | University of Alabama at Birmingham | 2007-04-01 |
| Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study (NCT00440193) | Bayer | 2007-03-01 |
| The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients (NCT00351663) | Shaare Zedek Medical Center | 2007-02-01 |
| Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers (NCT00436787) | University of Pittsburgh | 2007-02-01 |
| A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters (NCT00778336) | Boston Scientific Corporation | 2007-01-01 |
| Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT (NCT00585182) | University of Utah | 2007-01-01 |
| Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients (NCT00356759) | Hamilton Health Sciences Corporation | 2006-12-01 |
| PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption (NCT00457158) | Centre Hospitalier Universitaire de Saint Etienne | 2006-07-01 |
| Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome (NCT00395265) | University of Vermont | 2006-06-01 |
| Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery (NCT00306254) | Pfizer | 2006-03-01 |
| Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters (NCT00322270) | ARCA Biopharma, Inc. | 2006-01-01 |
| Cystic Fibrosis and Totally Implantable Vascular Access Devices (NCT00244270) | Assistance Publique - Hôpitaux de Paris | 2005-12-01 |
| A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. (NCT00246025) | Boehringer Ingelheim | 2005-10-01 |